[go: up one dir, main page]

AR121189A2 - Anticuerpos anti-tigit y métodos de uso - Google Patents

Anticuerpos anti-tigit y métodos de uso

Info

Publication number
AR121189A2
AR121189A2 ARP210100111A ARP210100111A AR121189A2 AR 121189 A2 AR121189 A2 AR 121189A2 AR P210100111 A ARP210100111 A AR P210100111A AR P210100111 A ARP210100111 A AR P210100111A AR 121189 A2 AR121189 A2 AR 121189A2
Authority
AR
Argentina
Prior art keywords
methods
tigit antibodies
tigit
antibodies
domained
Prior art date
Application number
ARP210100111A
Other languages
English (en)
Inventor
Jane L Grogan
Robert J Johnston
Yan Wu
Wei Liang
- Lupardus Patrick Ching
Mahesh Yadav
Dhaya Seshasayee
Meredith Hazen
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AR121189A2 publication Critical patent/AR121189A2/es

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente se refiere a anticuerpos anti-TIGIT (inmunoreceptor de células T con dominios de Ig e ITIM) y métodos de uso de los mismos.
ARP210100111A 2015-09-25 2021-01-18 Anticuerpos anti-tigit y métodos de uso AR121189A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562233230P 2015-09-25 2015-09-25

Publications (1)

Publication Number Publication Date
AR121189A2 true AR121189A2 (es) 2022-04-27

Family

ID=60931770

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP160102929A AR106146A1 (es) 2015-09-25 2016-09-26 Anticuerpos anti-tigit y métodos de uso
ARP210100111A AR121189A2 (es) 2015-09-25 2021-01-18 Anticuerpos anti-tigit y métodos de uso

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP160102929A AR106146A1 (es) 2015-09-25 2016-09-26 Anticuerpos anti-tigit y métodos de uso

Country Status (1)

Country Link
AR (2) AR106146A1 (es)

Also Published As

Publication number Publication date
AR106146A1 (es) 2017-12-13

Similar Documents

Publication Publication Date Title
CL2018000595A1 (es) Anticuerpos anti-pd1 y métodos de uso
ZA202401297B (en) Anti-tigit antibodies and methods of use
CL2020002540A1 (es) Anticuerpos anti-hla-g y utilización de los mismos
CL2019002824A1 (es) Anticuerpos anti-lag3.
CO2017013351A2 (es) Moduladores cot y métodos de uso de los mismos
ECSP18007905A (es) Anticuerpos monoclonales contra bcma
MX2017005920A (es) Anticuerpos anti-tim3 y metodos de uso.
CO2020012360A2 (es) Anticuerpos multiespecíficos y utilización de los mismos
CR20150618A (es) Anticuerpos receptores de antitransferina y métodos de uso
ECSP18000844A (es) Anticuerpos de unión a tau
BR112015032224A2 (pt) anticorpos anti-fcrh5
MX2015017341A (es) Anticuerpos anti-factor del complemento c1q y uso de los mismos.
MX386587B (es) ANTICUERPOS ANTI-CD79b Y MÉTODOS DE USO.
CR20160500A (es) Anticuerpos anti-ox40 y métodos de uso
CL2016002455A1 (es) Anticuerpos multiespecíficos.
MX2017007585A (es) Anticuerpos anti-c10orf54 y usos de los mismos.
MX2016005631A (es) Anticuerpos anti-alfa-sinucleina y metodos de uso.
MX2017015042A (es) Anticuerpos cd123 y conjugados de los mismos.
ECSP18000887A (es) Anticuerpos de unión a tau
MX372675B (es) Anticuerpos anti-jagged1 y metodos de uso.
CR20160270A (es) ANTICUERPOS ANTI-TAU (pS422) HUMANIZADOS Y MÉTODOS DE UTILIZACIÓN
CL2018001139A1 (es) Anticuerpos anti-htra1 y métodos de uso de los mismos.
AR121189A2 (es) Anticuerpos anti-tigit y métodos de uso
AR113854A1 (es) Anticuerpos anti-cxcr5, composiciones y usos de los mismos